Michael H. Goldstein - President, Ophthalmology & CMO at Ocular Therapeutix, Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
President, Ophthalmology & CMO
Stock Symbol
OCUL on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Michael H. Goldstein since 9/17/2023

Holdings reported by Michael H. Goldstein for Ocular Therapeutix, Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 313K $1.54M $4.93 Feb 3, 2022 Direct
Stock Option (Right to Buy) 190K Feb 3, 2022 Direct Common Stock

Transactions reported by Michael H. Goldstein for Ocular Therapeutix, Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.